Abstract
Polymyxin B has been shown to prevent endotoxin-induced mortality of mice and rabbits (9, 10), and to decrease the incidence of endotoxindisseminated intravascular coagulation (1). However, its use is limited only to oral or local administration because of its strong side effect on the central nervous system and the kidneys. Therefore, it cannot be used by intravenous injection for the therapy of endotoxemia. To solve problems, a new method of preparing polymyxin B by fixing it to an insoluble fiber was developed. We previously reported that polymyxin B would be covalently coupled to an insoluble fiber and could not be removed anymore by washing with isotonic saline (1, 3).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Corrigan, J. J. and Bell, B. M., 1917, Comparison between the polymyxins and gentamicin in preventing endotoxin-induced intravascular coagulation and leukopenia. Infect. Immun. 4: 563.
Dunn, D. L. and Ferguson, R. M., 1982, Immunotherapy of gram-negative bacterial sepsis: Enhanced survival in a guinea pig model by use of rabbit antiserum to Escherichia coli J5. Surgery 92: 212.
Hanasawa, K., Tani, T., Oka, T., Yoshioka, T., Endo, Y., Horisawa, M., Nakane, Y., Kodama, M., Teramoto, K. and Nishiumi, S., 1984, A new treatment for endotoxemia with direct hemoperfusion by polymyxin immobilized fiber, in: “Therapeutic apheresis: a critical look,” Y. Nose, P. S. Malchesky and J. W. Smith, eds., Cleveland: ISAO Press,: 167.
Kanoh, S., Yoshida, M., Kobayashi, T. and Ogawa, S., 1966, Studies on pyrogen (I). Jpn. J. Pharmacol. 62: 135.
Kodama, M., Oka, T., Tani, T. and Hanasawa, K., 1985, Therapeutic plasmapheresis for hepatic disorder in surgical patients new strategies for dealing with hyperbilirubinemia, endotoxemia and hemorrhagic disorder, in: “Current practice in therapeutic plasmaphoresis,” T. Hoshino, ed., Excerpta Medica, Amsterdam, p. 102.
Nolan, J. P., Mcdevitt, J. J. and Goldmann, G. S., 1975, Endotoxin binding by charged and uncharged resin. Proc. Soc. Exp. Biol. Med. 149: 766.
Obayashi, T., 1984, Addition of perchloric acid to blood samples for colorimetric limulus test using chromogenic substrate: Comparison with conventional procedures and clinical applications. J. Lab. Clin. Med. 104: 321.
Pineda, A. A. and Taswell, H. F., 1981, Selective plasma component removal: alternatives to plasma exchange. Artif Organs 5: 234.
Rifkind, D., 1967, Prevention by polymyxin B of endotoxin lethality in mice. J. Bacteriol. 93: 1463.
Rifkind, D. and Hill, B. J., Rolla, 1967, Neutralization of the Shwartzman reactions by polymyxin B. J. Immunol. 99: 564.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kodama, M., Hanasawa, K., Tani, T. (1990). New Therapeutic Method Against Septic Shock — Removal of Endotoxin Using Extracorporeal Circulation. In: Friedman, H., Klein, T.W., Nakano, M., Nowotny, A. (eds) Endotoxin. Advances in Experimental Medicine and Biology, vol 256. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5140-6_60
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5140-6_60
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-5142-0
Online ISBN: 978-1-4757-5140-6
eBook Packages: Springer Book Archive